Chang HY - Search Results

1

Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis.

Chang HY, Wu S, Li Y, Zhang W, Burrell M, Webster CI, Shah DK. Chang HY, et al. MAbs. 2021 Jan-Dec;13(1):1874121. doi: 10.1080/19420862.2021.1874121. MAbs. 2021. PMID: 33499723 Free PMC article.

2

Antibody pharmacokinetics in rat brain determined using microdialysis.

Chang HY, Morrow K, Bonacquisti E, Zhang W, Shah DK. Chang HY, et al. MAbs. 2018 Aug/Sep;10(6):843-853. doi: 10.1080/19420862.2018.1473910. Epub 2018 Aug 6. MAbs. 2018. PMID: 29944439 Free PMC article.

3

A translational platform PBPK model for antibody disposition in the brain.

Chang HY, Wu S, Meno-Tetang G, Shah DK. Chang HY, et al. J Pharmacokinet Pharmacodyn. 2019 Aug;46(4):319-338. doi: 10.1007/s10928-019-09641-8. Epub 2019 May 21. J Pharmacokinet Pharmacodyn. 2019. PMID: 31115858 Free PMC article.

4

Effect of Size on Solid Tumor Disposition of Protein Therapeutics.

Li Z, Li Y, Chang HP, Chang HY, Guo L, Shah DK. Li Z, et al. Among authors: chang hy, chang hp. Drug Metab Dispos. 2019 Oct;47(10):1136-1145. doi: 10.1124/dmd.119.087809. Epub 2019 Aug 6. Drug Metab Dispos. 2019. PMID: 31387870 Free PMC article.

5

Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models.

Chowdhury EA, Meno-Tetang G, Chang HY, Wu S, Huang HW, Jamier T, Chandran J, Shah DK. Chowdhury EA, et al. Among authors: chang hy. Adv Drug Deliv Rev. 2021 Mar;170:214-237. doi: 10.1016/j.addr.2021.01.017. Epub 2021 Jan 21. Adv Drug Deliv Rev. 2021. PMID: 33486008 Review.

6

Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in the Mouse Eye Following Systemic Administration.

Bussing D, Li Z, Li Y, Chang HP, Chang HY, Guo L, Verma A, Shah DK. Bussing D, et al. Among authors: chang hy, chang hp. AAPS J. 2021 Nov 8;23(6):116. doi: 10.1208/s12248-021-00647-0. AAPS J. 2021. PMID: 34750690 Free PMC article.

7

Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system.

Chang HY, Wu S, Chowdhury EA, Shah DK. Chang HY, et al. J Pharmacokinet Pharmacodyn. 2022 Jun;49(3):337-362. doi: 10.1007/s10928-021-09800-w. Epub 2022 Jan 29. J Pharmacokinet Pharmacodyn. 2022. PMID: 35092540

8

Effect of the Size of Protein Therapeutics on Brain Pharmacokinetics Following Systematic Administration.

Chang HY, Wu S, Li Y, Guo L, Li Y, Shah DK. Chang HY, et al. AAPS J. 2022 May 2;24(3):62. doi: 10.1208/s12248-022-00701-5. AAPS J. 2022. PMID: 35501500

9

Correction: Effect of the Size of Protein Therapeutics on Brain Pharmacokinetics Following Systematic Administration.

Chang HY, Wu S, Li Y, Guo L, Li Y, Shah DK. Chang HY, et al. AAPS J. 2022 May 24;24(4):69. doi: 10.1208/s12248-022-00718-w. AAPS J. 2022. PMID: 35612647 No abstract available.

10

Investigation of Antibody Pharmacokinetics in the Brain Following Intra-CNS Administration and Development of PBPK Model to Characterize the Data.

Wu S, Chang HY, Chowdhury EA, Huang HW, Shah DK. Wu S, et al. Among authors: chang hy. AAPS J. 2024 Mar 5;26(2):29. doi: 10.1208/s12248-024-00898-7. AAPS J. 2024. PMID: 38443635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,176 results

Search Page

Filters